New filgrastim drug Biograstim® given the green light for market authorisation and distribution by European Commission (EC) and EMA.
Home / Search Results
Stay informed about important legal and industry news with our blogs and weekly BioBlast® updates.
SUBSCRIBE TO PEARCE IP